1	Regulation	regulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	interleukin-2	interleukin-2	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	alpha	alpha	_	_	_	_	_	_	_
6	chain	chain	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	nuclear	nuclear	_	_	_	_	_	_	_
10	factor.kappa	factor.kappa	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	protein	protein	_	_	_	_	_	_	_
15	kinase	kinase	_	_	_	_	_	_	_
16	C	C	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	lymphocytes	lymphocyte	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Autocrine	Autocrine	_	_	_	_	_	_	_
2	role	role	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	tumor	tumor	_	_	_	_	_	_	_
5	necrosis	necrosis	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	alpha	alpha	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	regulation	regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	interleukin-2	interleukin-2	_	_	_	_	_	_	_
5	receptor	receptor	_	_	_	_	_	_	_
6	alpha	alpha	_	_	_	_	_	_	_
7	chain	chain	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	IL-2R	IL-2R	_	_	_	_	_	_	_
10	alpha	alpha	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	nuclear	nuclear	_	_	_	_	_	_	_
15	factor	factor	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	NF	NF	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	kinase	kinase	_	_	_	_	_	_	_
23	C	C	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	PKC	PKC	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	resting	rest	_	_	_	_	_	_	_
29	T	t	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	has	have	_	_	_	_	_	_	_
33	been	be	_	_	_	_	_	_	_
34	studied	study	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	resting	rest	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	phorbol	phorbol	_	_	_	_	_	_	_
9	esters	ester	_	_	_	_	_	_	_
10	strongly	strongly	_	_	_	_	_	_	_
11	induced	induce	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	IL-2R	IL-2R	_	_	_	_	_	_	_
16	alpha	alpha	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	NF.kappa	NF.kappa	_	_	_	_	_	_	_
22	B.	B.	_	_	_	_	_	_	_
23	This	this	_	_	_	_	_	_	_
24	activation	activation	_	_	_	_	_	_	_
25	was	be	_	_	_	_	_	_	_
26	due	due	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	translocation	translocation	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	p65	p65	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	c-Rel	c-rel	_	_	_	_	_	_	_
34	NF.kappa	NF.kappa	_	_	_	_	_	_	_
35	B	B	_	_	_	_	_	_	_
36	proteins	protein	_	_	_	_	_	_	_
37	from	from	_	_	_	_	_	_	_
38	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
39	stores	store	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	nucleus	nucleus	_	_	_	_	_	_	_
43	,	,	_	_	_	_	_	_	_
44	where	where	_	_	_	_	_	_	_
45	they	they	_	_	_	_	_	_	_
46	bound	bind	_	_	_	_	_	_	_
47	the	the	_	_	_	_	_	_	_
48	kappa	kappa	_	_	_	_	_	_	_
49	B	B	_	_	_	_	_	_	_
50	sequence	sequence	_	_	_	_	_	_	_
51	of	of	_	_	_	_	_	_	_
52	the	the	_	_	_	_	_	_	_
53	IL-2R	IL-2R	_	_	_	_	_	_	_
54	alpha	alpha	_	_	_	_	_	_	_
55	promoter	promoter	_	_	_	_	_	_	_
56	either	either	_	_	_	_	_	_	_
57	as	as	_	_	_	_	_	_	_
58	p50.p65	p50.p65	_	_	_	_	_	_	_
59	or	or	_	_	_	_	_	_	_
60	as	as	_	_	_	_	_	_	_
61	p50.c-Rel	p50.c-rel	_	_	_	_	_	_	_
62	heterodimers	heterodimer	_	_	_	_	_	_	_
63	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	all	all	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	those	those	_	_	_	_	_	_	_
6	events	event	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	largely	largely	_	_	_	_	_	_	_
9	indirect	indirect	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	mediated	mediate	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	endogenously	endogenously	_	_	_	_	_	_	_
14	secreted	secrete	_	_	_	_	_	_	_
15	tumor	tumor	_	_	_	_	_	_	_
16	necrosis	necrosis	_	_	_	_	_	_	_
17	factor	factor	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	TNF	TNF	_	_	_	_	_	_	_
21	alpha	alpha	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	as	as	_	_	_	_	_	_	_
25	they	they	_	_	_	_	_	_	_
26	were	be	_	_	_	_	_	_	_
27	strongly	strongly	_	_	_	_	_	_	_
28	inhibited	inhibit	_	_	_	_	_	_	_
29	by	by	_	_	_	_	_	_	_
30	a	a	_	_	_	_	_	_	_
31	neutralizing	neutralize	_	_	_	_	_	_	_
32	anti-TNF	anti-tnf	_	_	_	_	_	_	_
33	alpha	alpha	_	_	_	_	_	_	_
34	monoclonal	monoclonal	_	_	_	_	_	_	_
35	antibody	antibody	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	cyclosporin	cyclosporin	_	_	_	_	_	_	_
4	A	A	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	which	which	_	_	_	_	_	_	_
7	blocked	block	_	_	_	_	_	_	_
8	TNF	TNF	_	_	_	_	_	_	_
9	alpha	alpha	_	_	_	_	_	_	_
10	production	production	_	_	_	_	_	_	_
11	induced	induce	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	PKC	PKC	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	strongly	strongly	_	_	_	_	_	_	_
16	inhibited	inhibit	_	_	_	_	_	_	_
17	IL-2R	IL-2R	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	NF.kappa	NF.kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	activation	activation	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	either	either	_	_	_	_	_	_	_
5	TNF	TNF	_	_	_	_	_	_	_
6	alpha	alpha	_	_	_	_	_	_	_
7	or	or	_	_	_	_	_	_	_
8	IL-2	il-2	_	_	_	_	_	_	_
9	partially	partially	_	_	_	_	_	_	_
10	recovered	recover	_	_	_	_	_	_	_
11	cyclosporin	cyclosporin	_	_	_	_	_	_	_
12	A-induced	a-induced	_	_	_	_	_	_	_
13	IL-2R	IL-2R	_	_	_	_	_	_	_
14	alpha	alpha	_	_	_	_	_	_	_
15	inhibition	inhibition	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	but	but	_	_	_	_	_	_	_
18	only	only	_	_	_	_	_	_	_
19	TNF	TNF	_	_	_	_	_	_	_
20	alpha	alpha	_	_	_	_	_	_	_
21	completely	completely	_	_	_	_	_	_	_
22	recovered	recover	_	_	_	_	_	_	_
23	NF.kappa	NF.kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	activation	activation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Those	those	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	resting	rest	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	PKC	PKC	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	has	have	_	_	_	_	_	_	_
14	only	only	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	triggering	trigger	_	_	_	_	_	_	_
17	role	role	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	whereas	whereas	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	endogenously	endogenously	_	_	_	_	_	_	_
22	secreted	secrete	_	_	_	_	_	_	_
23	TNF	TNF	_	_	_	_	_	_	_
24	alpha	alpha	_	_	_	_	_	_	_
25	plays	play	_	_	_	_	_	_	_
26	an	an	_	_	_	_	_	_	_
27	essential	essential	_	_	_	_	_	_	_
28	role	role	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	quantitative	quantitative	_	_	_	_	_	_	_
32	control	control	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	expression	expression	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	IL-2R	IL-2R	_	_	_	_	_	_	_
38	alpha	alpha	_	_	_	_	_	_	_
39	chain	chain	_	_	_	_	_	_	_
40	or	or	_	_	_	_	_	_	_
41	NF.kappa	NF.kappa	_	_	_	_	_	_	_
42	B	B	_	_	_	_	_	_	_
43	activation	activation	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

